Kemper Awarded $84.3 Mln Plus Interest in Arbitration

Kemper Awarded $84.3 Mln Plus Interest in Arbitration

Kemper (KMPR) said it received a favorable ruling in a confidential arbitration proceeding against a software vendor and has been awarded $84.3 million plus interest. Separately, it said it expects Q3 results will include pre-tax catastrophe losses between $30 million to $37 million, including the impacts of Hurricanes Harvey and Irma and adverse development from re-estimates of losses from catastrophes that occurred in the first half of 2017. Except for […]

Read More ˃
Sonic Automotive Issues Q3 EPS Guidance Below Street Estimates Due to Impact of Hurricanes Harvey and Irma

Sonic Automotive Issues Q3 EPS Guidance Below Street Estimates Due to Impact of Hurricanes Harvey and Irma

Sonic Automotive (SAH) provided late Wednesday guidance for Q3 and fiscal 2017, including the negative impact of Hurricanes Harvey and Irma on its operations, with a Q3 outlook below Street expectations. Shares were down 3.1% in the after hours session. Sonic said it expects to report GAAP earnings per share from continuing operations for Q3 ranging between $0.44 and $0.46 and adjusted earnings per share from continuing operations ranging between […]

Read More ˃
Five Prime Therapeutics to Discuss Antibody Cancer Therapy at November Conference

Five Prime Therapeutics to Discuss Antibody Cancer Therapy at November Conference

Five Prime Therapeutics Inc. (FPRX), an early-stage specialty drugmaker, tonight said it will be a late selection to address an upcoming industry conference, with the company discussing initial data from Phase Ia/Ib testing of a combination of its CSF-1R and cabiralizumab antibodies with Bristol-Myers Squibb’s Opdivo PD-1 immune checkpoint inhibitor as a potential treatment in patients advanced solid tumors. The oral presentation is slated for Saturday, Nov. 11, at the […]

Read More ˃
Financial Stocks Drifting Back Near Even for Today’s Session

Financial Stocks Drifting Back Near Even for Today’s Session

Financial stocks were edging lower, with the NYSE Financial Sector Index dropping slightly more than 0.1% while financial companies in the S&P 500 Index were slipping about 0.1%. In company news, shares of the Pra Group (PRAA) fell as much as 7.5% on Wednesday, sliding to a session low of $27.90 each, after analysts at Janney lowered their investment rating for the specialty finance company to Sell from Neutral and […]

Read More ˃
XOMA Signs Licensing Deals for its Proprietary Phage Display Libraries for Antibody Discovery – Shares Rise

XOMA Signs Licensing Deals for its Proprietary Phage Display Libraries for Antibody Discovery – Shares Rise

Shares of XOMA Corp. (XOM) climbed more than 1.5% intraday after the company said it signed new non-exclusive licensing agreements with three companies – Tizona Therapeutics, Torch Biosciences, and LakePharma – for the use of its proprietary phage display libraries for antibody discovery. “Increasing our universe of licensees to XOMA’s hallmark proprietary phage display libraries is one of our key strategic initiatives in 2017,” CEO Jim Neal said. Phage display […]

Read More ˃